TSXV:VER.H - Post by User
Comment by
bullboardmonkeyon Dec 16, 2014 10:54pm
141 Views
Post# 23238568
RE:Here is another opionion
RE:Here is another opionionI agree that placing a device in the appropriate environment that will best utilize its abilities is an important requirement for the financial success of that device. MoleMate, like MelaFind, both have a niche in the marketplace, however will never exceed that confine. Quick time of use, ease of use, and accuracy in both Sensitivity and Specificity is the "Holy Grail" of a universally embraced skin cancer detection device. Aura has the best of class attributes in all these categories. Sadly, even though the Specificity of Aura is superior to the rest of the marketed devices, it still falls a great distance short of what is needed for it to be embraced by the world. Aura has received a lot of attention in the Media, and if the Specificity were anywhere near that of its Sensitivity to detecting skin cancer, our stock price would be above ten dollars. It is interesting to note that in the current MD&A, management referenced possibly combining technologies to gain improved accuracy